India's Central Drugs Standard Control Organization, the nation's drug regulator, sent a letter on Aug. 6 to state authorities outlining mandatory practices for inspecting drug manufacturing facilities. They include making improvements to the inspector qualification process, tightening protocols for inspections and publishing reports in a more timely fashion.

Related Summaries